|Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis|
DC Mabey, KA Sollis, HA Kelly, AS Benzaken, E Bitarakwate, ...
PLoS Med 9 (6), e1001233, 2012
|Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …|
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
|Is antenatal syphilis screening still cost effective in sub-Saharan Africa|
F Terris-Prestholt, D Watson-Jones, K Mugeye, L Kumaranayake, L Ndeki, ...
Sexually transmitted infections 79 (5), 375-381, 2003
|Sustainable HIV treatment in Africa through viral-load-informed differentiated care|
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
|Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?|
RG White, KK Orroth, JR Glynn, EE Freeman, R Bakker, JDF Habbema, ...
Journal of acquired immune deficiency syndromes (1999) 47 (3), 346, 2008
|Antenatal syphilis screening in sub‐Saharan Africa: lessons learned from Tanzania|
D Watson‐Jones, M Oliff, F Terris‐Prestholt, J Changalucha, B Gumodoka, ...
Tropical Medicine & International Health 10 (9), 934-943, 2005
|Crowdsourcing HIV test promotion videos: a noninferiority randomized controlled trial in China|
W Tang, L Han, J Best, Y Zhang, K Mollan, J Kim, F Liu, M Hudgens, ...
Clinical infectious diseases 62 (11), 1436-1442, 2016
|Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in …|
P Vickerman, F Terris-Prestholt, S Delany, L Kumaranayake, H Rees, ...
Sexually transmitted diseases 33 (10), S122-S132, 2006
|Managing men: women's dilemmas about overt and covert use of barrier methods for HIV prevention|
C MacPhail, F Terris-Prestholt, L Kumaranayake, P Ngoako, C Watts, ...
Culture, health & sexuality 11 (5), 485-497, 2009
|How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity|
M Quaife, F Terris-Prestholt, GL Di Tanna, P Vickerman
The European journal of health economics 19 (8), 1053-1066, 2018
|‘I will choose when to test, where I want to test’: investigating young people's preferences for HIV self-testing in Malawi and Zimbabwe|
PP Indravudh, EL Sibanda, M d’Elbée, MK Kumwenda, B Ringwald, ...
AIDS (London, England) 31 (Suppl 3), S203, 2017
|Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale|
W Quentin, Y Adu‐Sarkodie, F Terris‐Prestholt, R Legood, BK Opoku, ...
Tropical medicine & international health 16 (3), 379-389, 2011
|How much demand for new HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa|
F Terris-Prestholt, K Hanson, C MacPhail, P Vickerman, H Rees, C Watts
PloS one 8 (12), e83193, 2013
|Modelling the cost-effectiveness of introducing rapid syphilis tests into an antenatal syphilis screening programme in Mwanza, Tanzania|
P Vickerman, RW Peeling, F Terris-Prestholt, J Changalucha, D Mabey, ...
Sexually transmitted infections 82 (suppl 5), v38-v43, 2006
|Financing essential HIV services: a new economic agenda|
A Vassall, M Remme, C Watts, T Hallett, M Siapka, P Vickerman, ...
PLoS Med 10 (12), e1001567, 2013
|Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania|
W Quentin, F Terris-Prestholt, J Changalucha, S Soteli, WJ Edmunds, ...
BMC medicine 10 (1), 137, 2012
|Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis|
RF Baggaley, MA Irvine, W Leber, V Cambiano, J Figueroa, H McMullen, ...
The lancet HIV 4 (10), e465-e474, 2017
|HIV intertest interval among MSM in King County, Washington|
DA Katz, JC Dombrowski, F Swanson, SE Buskin, MR Golden, JD Stekler
Sexually transmitted infections 89 (1), 32-37, 2013
|Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial|
W Leber, H McMullen, J Anderson, N Marlin, AC Santos, S Bremner, ...
The lancet HIV 2 (6), e229-e235, 2015
|Divergent preferences for HIV prevention: a discrete choice experiment for multipurpose HIV prevention products in South Africa|
M Quaife, R Eakle, MA Cabrera Escobar, P Vickerman, ...
Medical Decision Making 38 (1), 120-133, 2018